Apyx Medical (APYX) Net Cash Flow (2011 - 2026)

Apyx Medical has reported Net Cash Flow for 16 years, with the latest figure at -$549000.0 in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 25.0% year-over-year to -$549000.0; the trailing twelve-month figure through Mar 2026 stood at $649000.0 (up 110.18% YoY), and the FY2025 full-year result was $466000.0, up 103.88% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$549000.0, down from $6.7 million in the prior quarter.
• The five-year high for Net Cash Flow was $21.5 million in Q4 2023, with the low at -$6.4 million in Q1 2024.
• Historically, Net Cash Flow has averaged $27705.9 across 5 years, with a median of -$1.5 million in 2025.
• Annual changes were most pronounced in 2022 — Net Cash Flow plunged 2882.17% — and 2023, when it surged 560.04%.
• Apyx Medical's Net Cash Flow stood at -$4.7 million in 2022, then surged by 560.04% to $21.5 million in 2023, then sank by 83.39% to $3.6 million in 2024, then soared by 86.72% to $6.7 million in 2025, then tumbled by 108.22% to -$549000.0 in 2026.
• The last three Net Cash Flow figures came in at -$549000.0 (Q1 2026), $6.7 million (Q4 2025), and -$4.0 million (Q3 2025), per Business Quant data.